TSHA (STOCKS)
Taysha Gene Therapies, Inc. Common Stock
$6.070000
-0.335000 (-5.23%)
Prev close: $6.405000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sean P. Nolan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,166.40M
- Employees
- 73
- P/E (TTM)
- -13.85
- P/B (TTM)
- 5.38
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.49M |
| Nonoperating Income/Loss | $3.53M |
| Operating Expenses | $158.64M |
| Research and Development | $123.14M |
| Other Operating Expenses | $35.50M |
| Operating Income/Loss | -$153.16M |
| Income/Loss From Continuing Operations After Tax | -$149.63M |
| Income/Loss From Continuing Operations Before Tax | -$149.63M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$149.63M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$149.63M |
| Net Income/Loss Available To Common Stockholders, Basic | -$149.63M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.41 |
| Diluted Earnings Per Share | -$0.41 |
| Basic Average Shares | 733,690,608 |
| Diluted Average Shares | 733,690,608 |
| Assets | $470.43M |
| Current Assets | $461.43M |
| Noncurrent Assets | $9.00M |
| Fixed Assets | $2.41M |
| Other Non-current Assets | $6.59M |
| Liabilities | $83.17M |
| Current Liabilities | $25.98M |
| Accounts Payable | $9.16M |
| Wages | $5.37M |
| Other Current Liabilities | $11.44M |
| Noncurrent Liabilities | $57.19M |
| Equity | $387.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $387.27M |
| Liabilities And Equity | $470.43M |
| Net Cash Flow From Operating Activities | -$132.19M |
| Net Cash Flow From Operating Activities, Continuing | -$132.19M |
| Net Cash Flow From Investing Activities | -$3.32M |
| Net Cash Flow From Investing Activities, Continuing | -$3.32M |
| Net Cash Flow From Financing Activities | $275.72M |
| Net Cash Flow From Financing Activities, Continuing | $275.72M |
| Net Cash Flow | $140.21M |
| Net Cash Flow, Continuing | $140.21M |
| Comprehensive Income/Loss | -$148.17M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$148.17M |
| Other Comprehensive Income/Loss | $1.47M |